Efficacy of a Single Dose of Aspirin vs. Acetaminophen in Tension Type Headache
NCT01552798 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 9
Last updated 2018-12-19
Summary
The purpose of this trial is to determine if a single, oral dose of a fast release aspirin 1000 mg provides relief compared to acetaminophen 1000 mg and placebo in subjects with tension-type headache pain.
Conditions
Interventions
- DRUG
-
Acetylsalicylic acid (Aspirin, BAY1019036)
2 x 500 mg fast release aspirin tablets (1000 mg) and 2 x placebo acetaminophen caplets
- DRUG
-
2 x 500 mg acetaminophen caplets (1000 mg) and 2 x placebo fast release aspirin tablets
- DRUG
-
2 x placebo acetaminophen caplets and 2 x placebo fast release aspirin tablets
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bayer Study Director · Bayer
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-03-12
- Primary Completion
- 2012-06-04
- Completion
- 2012-06-04
Countries
- United States
Study Locations
More Related Trials
-
Effect of Parcetamol in Headach
NCT06861738 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Paracetamol With Caffeine to Treat Episodic Tension Type Headache
NCT01755702 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety Clinical Trial of the Combination of Acetylsalicylic Acid, Sodium Bicarbonate and Citric Acid, Produced by Geolab Pharmaceutical Industries Ltd., Compared to Acetylsalicylic Acid (Aspirin ® - Bayer) in Patients With Episodic Tension-type Headache.
NCT01012349 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Prochlorperazine Versus Acetaminophen, Aspirin, and Caffeine for the Treatment of Acute Migraine
NCT01629329 ·Status: TERMINATED ·Phase: PHASE4
-
A Study of Rizatriptan Co-Administered With Acetaminophen for the Treatment of Acute Migraine
NCT00300924 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2)
NCT00383162 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy and Safety of Proprietary Formulations of Oral Ketamine + Aspirin in Treatment of Acute Headache
NCT04860713 ·Status: COMPLETED ·Phase: PHASE4
-
Single-Site Study of Naltrexone/Acetaminophen for the Acute Treatment of Migraine: A Phase 2 Randomized Trial
NCT05685225 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine
NCT00285402 ·Status: UNKNOWN ·Phase: PHASE2
-
The Preventive Treatment of Migraine With Low-Dose Naltrexone and Acetaminophen Combination
NCT03194555 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)
NCT00382993 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Test the Safety and Effectiveness of MK-0974 (Telcagepant) Co-administered With Ibuprofen or Acetaminophen in Patients With Migraines With or Without Aura (MK-0974-046)
NCT00758836 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Mild Headache in People Who Experience Migraines
NCT00690716 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Eslicarbazepine Acetate as Preventive Therapy for Subjects With Migraine
NCT01820559 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy and Safety of Intra-oral Topical Ketoprofen for the Treatment of Acute Migraine
NCT01228552 ·Status: UNKNOWN ·Phase: PHASE3
-
To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane Headaches
NCT00434083 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine
NCT02745392 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of Sumatriptan Naproxen Sodium Succinate Tablets for the Treatment of Acute Migraine Attacks
NCT04948164 ·Status: UNKNOWN ·Phase: PHASE3
-
Study to Test a Marketed Product in the Treatment of Migraine-associated Nausea
NCT00250458 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months
NCT00442221 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migraine Headaches
NCT00433732 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparative Efficacy Trial of IV Acetaminophen Versus IV Ketorolac for Emergency Department Treatment of Generalized Headache
NCT03472872 ·Status: WITHDRAWN ·Phase: PHASE4
-
Low-Dose Naltrexone and Acetaminophen Combination and Sumatriptan in the Acute Treatment of Migraine With Nausea
NCT03185143 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of Treatment Used for Migraine Headaches (MK-0974-076)
NCT01421277 ·Status: TERMINATED
-
Clinical Study Examining Use of an Over-the-Counter Supplement for the Prevention of Menstrually-Associated Migraine Headache
NCT00203255 ·Status: COMPLETED ·Phase: NA